Temperature matters! And why it should matter to tumor immunologists.
A major goal of cancer immunology is to stimulate the generation of long-lasting, tumor antigen-specific immune responses that recognize and destroy tumor cells. This article discusses advances in thermal medicine with the potential to improve cancer immunotherapy. Accumulating evidence indicates that survival benefits are accorded to individuals who achieve an increase in body temperature (i.e. fever) following infection. Furthermore, accumulating evidence indicates that physiological responses to hyperthermia impact the tumor microenvironment through temperature-sensitive check-points that regulate tumor vascular perfusion, lymphocyte trafficking, inflammatory cytokine expression, tumor metabolism, and innate and adaptive immune function. Nevertheless, the influence of thermal stimuli on the immune system, particularly the antitum or immune response, remains incompletely understood. In fact, temperature is still rarely considered as a critical variable in experimental immunology. We suggest that more attention should be directed to the role of temperature in the regulation of the immune response and that thermal therapy should be tested in conjunction with immunotherapy as a multi-functional adjuvant that modulates the dynamics of the tumor microenvironment.
Department of Immunology, Roswell Park Cancer Institute, Buffalo NY.
Elizabeth A
EA
Repasky
Department of Immunology, Roswell Park Cancer Institute, Buffalo NY.
Sharon S
SS
Evans
Department of Radiation Oncology, Duke University Medical Center Durham, NC 27710.
Mark W
MW
Dewhirst
D000818:Animals; D015687:Cell Hypoxia; D016207:Cytokines / Q000276:immunology; D005334:Fever / Q000276:immunology*; D006801:Humans; D006979:Hyperthermia, Induced; D007107:Immune System / Q000502:physiology*; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D013696:Temperature; D059016:Tumor Microenvironment
D016207:Cytokines